DE69710879T2 - Arzneimittel auf basis von progesteron und östradiol - Google Patents

Arzneimittel auf basis von progesteron und östradiol

Info

Publication number
DE69710879T2
DE69710879T2 DE69710879T DE69710879T DE69710879T2 DE 69710879 T2 DE69710879 T2 DE 69710879T2 DE 69710879 T DE69710879 T DE 69710879T DE 69710879 T DE69710879 T DE 69710879T DE 69710879 T2 DE69710879 T2 DE 69710879T2
Authority
DE
Germany
Prior art keywords
pct
oil
progesterone
östradiol
dissolve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69710879T
Other languages
English (en)
Other versions
DE69710879D1 (de
Inventor
Dominique Salin-Drouin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Besins Iscovesco SA
Original Assignee
Laboratoires Besins Iscovesco SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Besins Iscovesco SA filed Critical Laboratoires Besins Iscovesco SA
Application granted granted Critical
Publication of DE69710879D1 publication Critical patent/DE69710879D1/de
Publication of DE69710879T2 publication Critical patent/DE69710879T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
DE69710879T 1996-04-05 1997-04-04 Arzneimittel auf basis von progesteron und östradiol Expired - Lifetime DE69710879T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9604349A FR2747042B1 (fr) 1996-04-05 1996-04-05 Medicament a base de progesterone et d'oestradiol
PCT/FR1997/000612 WO1997037642A1 (fr) 1996-04-05 1997-04-04 Medicament a base de progesterone et d'oestradiol

Publications (2)

Publication Number Publication Date
DE69710879D1 DE69710879D1 (de) 2002-04-11
DE69710879T2 true DE69710879T2 (de) 2002-11-14

Family

ID=9490985

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69710879T Expired - Lifetime DE69710879T2 (de) 1996-04-05 1997-04-04 Arzneimittel auf basis von progesteron und östradiol

Country Status (9)

Country Link
US (1) US6077531A (de)
EP (1) EP0896529B1 (de)
JP (1) JP2000508309A (de)
AT (1) ATE213934T1 (de)
CA (1) CA2251002C (de)
DE (1) DE69710879T2 (de)
ES (1) ES2172782T3 (de)
FR (1) FR2747042B1 (de)
WO (1) WO1997037642A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028057A (en) * 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
FR2777784B1 (fr) * 1998-04-27 2004-03-19 Arepa Composition pharmaceutique a base d'estrogene et de progesterone
US6544553B1 (en) * 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
FR2832065B1 (fr) * 2001-11-13 2004-11-05 Besins Int Belgique Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations
AU2003208679A1 (en) 2002-02-08 2003-09-02 Advanced Animal Technology Limited Control of a biological function
ES2537551T3 (es) * 2003-06-13 2015-06-09 Skendi Finance, Ltd. Formulación de estradiol-progesterona de liberación lenta
CA2540838C (en) 2003-10-03 2014-12-16 Thorn Bioscience, Llc Process for the synchronization of ovulation for timed breeding without heat detection
US8075910B2 (en) * 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
BRPI1014362A2 (pt) 2009-04-23 2016-04-05 Pennatek Llc método e composição para sincronizar o tempo de inseminação
WO2011073995A2 (en) 2009-12-14 2011-06-23 Lincoln Pharmaceuticals Limited Liquid vaginal spray of progesterone
UY33103A (es) * 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
JP2016508030A (ja) 2012-11-28 2016-03-17 ジェイビーエス ユナイテッド アニマル ヘルス セカンド エルエルシー 未経産ブタにおける授精の時期を同期化するための方法および組成物
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
MX2016013693A (es) 2014-07-29 2017-10-31 Therapeuticsmd Inc Crema transdermica.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
EP3435977A4 (de) 2016-04-01 2019-10-16 Therapeuticsmd, Inc. Pharmazeutische steroidhormonzusammensetzung
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4624665A (en) * 1984-10-01 1986-11-25 Biotek, Inc. Method of transdermal drug delivery
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
WO1995000125A1 (en) * 1993-06-18 1995-01-05 Smithkline Beecham Corporation Soft-shelled gelatin encapsulated particles

Also Published As

Publication number Publication date
US6077531A (en) 2000-06-20
ES2172782T3 (es) 2002-10-01
EP0896529B1 (de) 2002-03-06
CA2251002A1 (fr) 1997-10-16
EP0896529A1 (de) 1999-02-17
JP2000508309A (ja) 2000-07-04
FR2747042B1 (fr) 1998-06-05
ATE213934T1 (de) 2002-03-15
DE69710879D1 (de) 2002-04-11
FR2747042A1 (fr) 1997-10-10
WO1997037642A1 (fr) 1997-10-16
CA2251002C (fr) 2007-01-30

Similar Documents

Publication Publication Date Title
DE69710879T2 (de) Arzneimittel auf basis von progesteron und östradiol
DE59604603D1 (de) Arzneiform zur abgabe von wirkstoffen an wunden
DE69328550T2 (de) Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln
FR2743712B1 (fr) Dispositif d'ancrage d'osteosynthese vertebrale posterieure
DE69228997D1 (de) Menschliche il-3-varianten
ATE213630T1 (de) Verwendung vonsisovaleramid als mildes anxiolytisches und sedatives mittel
FR2731907B1 (fr) Composition dermatologique et/ou cosmetique depigmentante et utilisation dans une methode cosmetique
DE69711078T2 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
DE69328193D1 (de) Verwendung von prodelphidinen zur behandlung von arthrose
DE59100496D1 (de) Verwendung von selektiv hydrierten Styrol-Butadien-Copolymerisaten in kosmetischen und pharmazeutischen Zubereitungen.
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
ATE135223T1 (de) Arzneimittel zur behandlung von hyperlipidämie und/oder atherosklerose
AU3851095A (en) Assay
NO984651D0 (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
ATE207756T1 (de) Pharmazeutische zusammensetzung, die muirapuama und pflanzenwürmer enthaelt
FR2718024B1 (fr) Médicament et composition pharmaceutique pour le traitement de l'inflammation.
Willcox Health scare
ATE291904T1 (de) 2,4-dichlorbenzylalkohol und amylmetakresol gegen hiv-infektion
FR2818147B1 (fr) Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine
Takahashi et al. On the Relationship between Abdominal Palpation Signs of Kampo Medicine and Abdominal Ultrasonographic Findings
SE9403861D0 (sv) Novel medicinal use
Richmond Doctor/patient interaction in the teaching hospital
Jezierski ELASTIC and ALERT: help for nurses and others with latex allergies, help for those who work with latex. Education for Latex Allergy/Support Team and Information Coalition. Allergy to Latex Education and Resource Team
Leone The Pharmacy and Drugs Act, 1988 (No. 1 of 1988), 3 March 1988
ES2141923T3 (es) Uso hipocolesterolemico, antiaterosclerotico e hipotrigliceridemico de derivados aminoacetilmercapto.

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: PATENTANWAELTE VON KREISLER, SELTING, WERNER ET CO